These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 9398052

  • 21. Susceptibility of p27 kip1 knockout mice to urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine may not simply be due to enhanced proliferation.
    Hikosaka A, Ogawa K, Sugiura S, Asamoto M, Takeshita F, Sato SY, Nakanishi M, Kohri K, Shirai T.
    Int J Cancer; 2008 Mar 15; 122(6):1222-8. PubMed ID: 18027869
    [Abstract] [Full Text] [Related]

  • 22. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
    Ozaki K, Sukata T, Yamamoto S, Uwagawa S, Seki T, Kawasaki H, Yoshitake A, Wanibuchi H, Koide A, Mori Y, Fukushima S.
    Cancer Res; 1998 Sep 01; 58(17):3806-11. PubMed ID: 9731488
    [Abstract] [Full Text] [Related]

  • 23. Chemopreventive efficacy of piroxicam administered alone or in combination with lycopene and beta-carotene on the development of rat urinary bladder carcinoma after N-butyl-N-(4-hydroxybutyl)nitrosamine treatment.
    Okajima E, Ozono S, Endo T, Majima T, Tsutsumi M, Fukuda T, Akai H, Denda A, Hirao Y, Okajima E, Nishino H, Nir Z, Konishi Y.
    Jpn J Cancer Res; 1997 Jun 01; 88(6):543-52. PubMed ID: 9263531
    [Abstract] [Full Text] [Related]

  • 24. 4-Hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers in mice: characterization of FHIT and survivin expression and chemopreventive effects of indomethacin.
    Lubet RA, Huebner K, Fong LY, Altieri DC, Steele VE, Kopelovich L, Kavanaugh C, Juliana MM, Soong SJ, Grubbs CJ.
    Carcinogenesis; 2005 Mar 01; 26(3):571-8. PubMed ID: 15591090
    [Abstract] [Full Text] [Related]

  • 25. Promoting effects of dimethylarsinic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats.
    Wanibuchi H, Yamamoto S, Chen H, Yoshida K, Endo G, Hori T, Fukushima S.
    Carcinogenesis; 1996 Nov 01; 17(11):2435-9. PubMed ID: 8968060
    [Abstract] [Full Text] [Related]

  • 26. Nucleolar organizer regions in rat urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Takeuchi T, Tanaka T, Ohno T, Yamamoto N, Kobayashi S, Kuriyama M, Kawada Y, Mori H.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1990 Nov 01; 58(5):383-7. PubMed ID: 1971134
    [Abstract] [Full Text] [Related]

  • 27. The diverse modification of N-butyl-N-(4-hydroxybutyl) nitrosamine induced carcinogenesis in urinary bladder by dibromodulcitol and dianhydrodulcitol.
    Szende B, Jeney A, Institoris L.
    Acta Morphol Hung; 1992 Nov 01; 40(1-4):187-93. PubMed ID: 1365762
    [Abstract] [Full Text] [Related]

  • 28. The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.
    Dai YC, Wang SC, Haque MM, Lin WH, Lin LC, Chen CH, Liu YW.
    PLoS One; 2017 Nov 01; 12(10):e0186214. PubMed ID: 29016672
    [Abstract] [Full Text] [Related]

  • 29. Significance of overexpression of metallothionein in mouse urinary bladder focal lesions induced by treatment with N-butyl-N-(4-hydroxybutyl)-nitrosamine.
    Mitsuhashi M, Wanibuchi H, Morimura K, Doi K, Wei M, Wada S, Nakatani T, Fukushima S.
    Cancer Sci; 2003 Dec 01; 94(12):1052-8. PubMed ID: 14662020
    [Abstract] [Full Text] [Related]

  • 30. Antiproliferative and anti-inflammatory properties of diindolylmethane and lupeol against N-butyl-N-(4-hydroxybutyl) nitrosamine induced bladder carcinogenesis in experimental rats.
    Prabhu B, Balakrishnan D, Sundaresan S.
    Hum Exp Toxicol; 2016 Jun 01; 35(6):685-92. PubMed ID: 26251508
    [Abstract] [Full Text] [Related]

  • 31. Potential effects of the herbicide Diuron on mammary and urinary bladder two-stage carcinogenesis in a female Swiss mouse model.
    de Moura NA, Grassi TF, Rodrigues MA, Barbisan LF.
    Arch Toxicol; 2010 Feb 01; 84(2):165-73. PubMed ID: 19902181
    [Abstract] [Full Text] [Related]

  • 32. Simultaneous treatment with benzyl isothiocyanate, a strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Okazaki K, Yamagishi M, Son HY, Imazawa T, Furukawa F, Nakamura H, Nishikawa A, Masegi T, Hirose M.
    Nutr Cancer; 2002 Feb 01; 42(2):211-6. PubMed ID: 12416262
    [Abstract] [Full Text] [Related]

  • 33. Inhibitory effect of an aromatic retinoic acid analog on urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Murasaki G, Miyata Y, Babaya K, Arai M, Fukushima S, Ito N.
    Gan; 1980 Jun 01; 71(3):333-40. PubMed ID: 7418979
    [Abstract] [Full Text] [Related]

  • 34. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary protocatechuic acid during initiation and postinitiation phases.
    Tanaka T, Kawamori T, Ohnishi M, Okamoto K, Mori H, Hara A.
    Cancer Res; 1994 May 01; 54(9):2359-65. PubMed ID: 8162581
    [Abstract] [Full Text] [Related]

  • 35. Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Okajima E, Denda A, Ozono S, Takahama M, Akai H, Sasaki Y, Kitayama W, Wakabayashi K, Konishi Y.
    Cancer Res; 1998 Jul 15; 58(14):3028-31. PubMed ID: 9679967
    [Abstract] [Full Text] [Related]

  • 36. Chemoprevention of 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis by the dietary flavonoids chalcone, 2-hydroxychalcone, and quercetin.
    Makita H, Tanaka T, Fujitsuka H, Tatematsu N, Satoh K, Hara A, Mori H.
    Cancer Res; 1996 Nov 01; 56(21):4904-9. PubMed ID: 8895742
    [Abstract] [Full Text] [Related]

  • 37. Comparative carcinogenicity of N-butyl-N-(3-carboxypropyl)-nitrosamine and N-butyl-N-(4-hydroxybutyl)nitrosamine for the urinary bladder of (C57BL/6 X DBA/2)F1 mice.
    Irving CC, Murphy WM, Daniel DS.
    J Natl Cancer Inst; 1984 Sep 01; 73(3):753-6. PubMed ID: 6590920
    [Abstract] [Full Text] [Related]

  • 38. Chemopreventive effects of bovine lactoferrin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat bladder carcinogenesis.
    Masuda C, Wanibuchi H, Sekine K, Yano Y, Otani S, Kishimoto T, Tsuda H, Fukushima S.
    Jpn J Cancer Res; 2000 Jun 01; 91(6):582-8. PubMed ID: 10874209
    [Abstract] [Full Text] [Related]

  • 39. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by citrus auraptene in rats.
    Tanaka T, Kawabata K, Kakumoto M, Matsunaga K, Mori H, Murakami A, Kuki W, Takahashi Y, Yonei H, Satoh K, Hara A, Maeda M, Ota T, Odashima S, Koshimizu K, Ohigashi H.
    Carcinogenesis; 1998 Mar 01; 19(3):425-31. PubMed ID: 9525276
    [Abstract] [Full Text] [Related]

  • 40. Lack of preventive efficacy of FK228, a histone deacetylase inhibitor, against N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary bladder carcinogenesis in p53+/- and p53+/+ mice.
    Wei M, Wanibuchi H, Morimura K, Salim EI, Moku M, Doi K, Mitsuhashi M, Masuda C, Shen J, Kinoshita A, Fukushima S.
    Anticancer Res; 2004 Mar 01; 24(2B):785-90. PubMed ID: 15161027
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.